Strongyloides hyperinfection syndrome (SHS) is a severe manifestation of the Strongyloides parasite, often occurring in immunocompromised patients due to the inability to subdue larvae autoinfection. As the parasitic burden increases, the patient can develop worsening respiratory symptoms that mimic common pathologies such as chronic obstructive pulmonary disease (COPD). The parasite is endemic to the Appalachian region as well as subtropical and tropical areas worldwide. Despite millions of cases reported annually, it is not commonly screened for in symptomatic high-risk patients. The mortality rate from SHS is high, and few studies have explored the effects of early Strongyloides screening on reducing mortality. This case report focuses on a 71-year-old male who was diagnosed with SHS after one month of progressive deterioration in the intensive care unit (ICU) from sepsis and acute respiratory failure. The significance of this case is to highlight the occurrence of SHS in immunocompromised patients and discuss the importance of early Strongyloides screening to mitigate mortality of symptomatic high-risk patients in endemic regions.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11744033PMC
http://dx.doi.org/10.7759/cureus.76106DOI Listing

Publication Analysis

Top Keywords

strongyloides hyperinfection
8
hyperinfection syndrome
8
syndrome shs
8
intensive care
8
care unit
8
unit icu
8
case report
8
immunocompromised patients
8
symptomatic high-risk
8
high-risk patients
8

Similar Publications

Strongyloides hyperinfection syndrome (SHS) is a severe manifestation of the Strongyloides parasite, often occurring in immunocompromised patients due to the inability to subdue larvae autoinfection. As the parasitic burden increases, the patient can develop worsening respiratory symptoms that mimic common pathologies such as chronic obstructive pulmonary disease (COPD). The parasite is endemic to the Appalachian region as well as subtropical and tropical areas worldwide.

View Article and Find Full Text PDF

Strongyloides stercoralis infection in a patient initiating corticosteroid therapy for hypereosinophilia: A case report.

Parasitol Int

December 2024

Department of Medical Microbiology, Faculty of Medicine, TOBB University of Economics and Technology, Ankara, Turkey; Department of Medical Microbiology, Faculty of Medicine, Cyprus International University, Nicosia, Cyprus.

Strongyloides stercoralis (S. stercoralis) is a soil-transmitted nematode that is endemic to tropical and subtropical regions. S.

View Article and Find Full Text PDF

Background: is one of the neglected tropical diseases. We aimed to verify the genetic diversity of with attention to clinical features of the infection in patients using the 1 gene and DNA sequencing.

Methods: Using parasitological methods, was isolated from stool samples of patients who had been referred to Tehran University of Medical Sciences, Tehran, Iran.

View Article and Find Full Text PDF

is an intestinal nematode. It is widely distributed in the tropics and sub-tropics of the world. It can cause a wide array of illnesses ranging from asymptomatic autoinfection to a severe form of hyperinfection and disseminated strongyloidiasis.

View Article and Find Full Text PDF

Strongyloides hyperinfection and disseminated infections are usually associated with immunosuppression; these severe manifestations occur in a minority of cases. The use of immunosuppressants such as corticosteroids and Baricitinib for treating COVID-19 pneumonia can be responsible for patients' immunosuppression and cause Strongyloides hyperinfection syndrome. The chance increases when the patient belongs to countries or regions where chronic infection with Strongyloides is more prevalent.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!